9th Annual Biomarkers Congress

Immunology: Stanford University

Total Score People Score Events Score
39 32 18
Date Event Presentation Speakers
October 31, 2013 (T1) Keystone Symposia: Advancing Vaccines in the Genomics Era Genomics of T Cell Responses to Vaccination Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting Scott D Boyd
Genomics of Antibody Responses to Vaccination Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting Scott D Boyd, Mark M. Davis
June 10, 2013 2nd International Conference on Gastroenterology & Urology Track 7 & 8 : Detrusor sphincter and detrusor anal sphincter dyssenergia; Its relevance to bladder and bowel dysfunctions. Inder Perkash
April 6, 2013 AACR Annual Meetings Developmental Origins of Cancer Chairperson: Richard J. Gilbertson, St. Jude Children's Research Hospital, Memphis, TN Roel Nusse­
Imaging the Cancer Cell In Vivo Chairperson: Ralph Weissleder, Massachusetts General Hospital, Boston, MA Sanjiv S. Gambhir
Emerging Single Cell Technologies in Cancer Research Chairperson: Garry P. Nolan, Stanford University School of Medicine, Stanford, CA Garry P Nolan
Noncoding RNAs and Cancer Chairperson: Phillip A. Sharp, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA Howard Y. Chang
Prostate Cancer Screening: Now and In the Future Co-Chairpersons: William G. Nelson, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, and Mark A. Rubin, Weill Cornell Medical College of Cornell University, New York, NY William G. Nelson
The Role of Stroma in Pancreatic Cancer Moderator: Kornelia Polyak, Dana-Farber Cancer Institute, Boston, MA Philip A Beachy
The MICR Forum: Precision Medicine in Cancer: Will There Be Equitable Benefits? William G. Nelson
Noncoding RNAs in Cancer: From Pathogenesis to Therapeutics Chairperson: Elsa R. Flores, The University of Texas MD Anderson Cancer Center, Houston, TX Michael F. Clarke,
New Insights Into p53 From Genetics and Genomics Laura D. Attardi, Stanford University School of Medicine, Stanford, CA L D Attardi,
New Approaches to Imaging Tumor Biology Sanjiv S. Gambhir
Techniques for Assessing Circulating Tumor Cells, Circulating DNA, and Exosomes: Pros and Cons Chairperson: Sanjiv Sam Gambhir, Stanford University, Stanford, CA Maximilian Diehn
Stem Cells, Enteroids, and Organoids: A New Era for In Vitro Models of the Intestine Calvin Kuo
December 2, 2012 Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances Session 8: From Regulatory Pathways to Multimodality Immunotherapy Approaches: A Translational Paradigm Ronald Levy
January 13, 2011 Immunology and metabolism Redox, HIV-Tat and lymphocytes: physiological oxygen in action Leonore HERZENBERG
November 30, 2010 Tumor Immunology in Conjunction with the Cancer Immunology Working Group of the AACR Curing metastatic colon tumors with combined vaccination, radiation and hematopoietic cell transplantation Samuel Strober
November 30, 2010 Tumor Immunology: Basic and Clinical Advances in Conjunction with the Cancer Immunology Working Group of the AACR Curing metastatic colon tumors with combined vaccination, radiation ,and hematopoietic cell transplantation Samuel Strober
September 25, 2010 The Management of Women with Chronic Immune Disorders in the Era of Biologics Putting risk into perspective: A case-based discussion Vibeke Strand
Emerging risks in women with immune disorders: Understanding premature cardiovascular disease and malignancy Vibeke Strand
Q&A with panel discussion: Maintaining health and quality of life Vibeke Strand
Quality of life and social connectivity for women: A comparison across immune disorders Vibeke Strand
Introductions and objectives Vibeke Strand
Summary and concluding remarks Vibeke Strand
Q&A with Panel discussion: Managing patient’s expectations on pregnancy Eliza Chakravarty
Fertility and pregnancy: The impact of chronic immune disorders and treatments Eliza Chakravarty
June 1, 2010 Emerging Themes in Infection Biology Play nice or play mean : how Toxoplasma injects polymorphic proteins that determine the character of its dance with the host John Boothroyd
Host-pathogen interactions during chronic Salmonella infections Denise M Monack,
April 8, 2010 MOOD and ANXIETY DISORDERS : SOLVING CLINICAL CHALLENGES, IMPROVING PATIENT CARE Maternal-Fetal Dyad: Risks and Benefits of Prescribing Psychotropics During Pregnancy Natalie Rasgon
Suicide Risk in Children, Adolescents, and Young Adults Kiki Chang
Bipolar + Anxiety + Substance Abuse in Kids Kiki Chang
Treating Postpartum Depression and Anxiety: Best Practices for Mother and Infant Natalie Rasgon
September 24, 2009 2009 UCSF Rheumatology Board Review P Rheumatoid Arthritis: Differential Diagnosis, Complications and Extra-Articular Features Lester D. Miller
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Session Chair : Track 1-6 (I) Craig Levin
In Vivo Reporter Gene Imaging: Track 1-6 (I) Craig Levin
Title: TBD :Track 2-5 Rupshi Mitra
May 30, 2008 ASCO Annual'08 Meeting general oncology sessions-- Adjuvant Chemotherapy for Non-Small Cell Lung Cancer: Who, What, and When? (CPO01A) Heather A. Wakelee
general oncology sessions-- Adjuvant Chemotherapy for Non-Small Cell Lung Cancer: Who, What, and When? (CPO01B) Heather A. Wakelee
geriatric oncology-- Adjuvant Chemotherapy for Non-Small Cell Lung Cancer: Who, What, and When? (CPO01A) Heather A. Wakelee
geriatric oncology-- Adjuvant Chemotherapy for Non-Small Cell Lung Cancer: Who, What, and When? (CPO01B) Heather A. Wakelee
leukemia, myelodysplasia, and transplantation-- The Many Faces of Myelodysplasia: Head-Turning Developments (CPO16) Peter Greenberg
lung cancer-- Adjuvant Chemotherapy for Non-Small Cell Lung Cancer: Who, What, and When? (CPO01A) Heather A. Wakelee
lung cancer-- Adjuvant Chemotherapy for Non-Small Cell Lung Cancer: Who, What, and When? (CPO01B) Heather A. Wakelee
lymphoma and plasma cell disorders-- Tumor Immunology: Advances in Therapeutic Vaccines for Cancer Ronald Levy
tumor biology-- Tumor Immunology: Advances in Therapeutic Vaccines for Cancer Ronald Levy
tumor biology-- Hypoxia as a Therapeutic Target Amato J Giaccia
clinical problems in oncology-- The Many Faces of Myelodysplasia: Head-Turning Developments (CPO16) Peter Greenberg
clinical problems in oncology-- Adjuvant Chemotherapy for Non-Small Cell Lung Cancer: Who, What, and When? (CPO01A) Heather A. Wakelee
clinical problems in oncology-- Adjuvant Chemotherapy for Non-Small Cell Lung Cancer: Who, What, and When? (CPO01B) Heather A. Wakelee
April 8, 2008 Molecular Evolution as a Driving Force in Infectious Diseases Workshop Bouke C. de Jong
Parasites and Host Evolution I Peter Parham, Peter Sarnow
April 8, 2008 Molecular Evolution as a Driving Force in Infectious Diseases Parasites and Host Evolution I Peter Parham, Peter Sarnow
April 8, 2008 Molecular Evolution as a Driving Force in Infectious Diseases Parasites and Host Evolution I Peter Parham, Peter Sarnow
March 2, 2008 MOLECULAR MECHANISMS IN LYMPHATIC FUNCTION & DISEASE Treatment of Lymphatic Dysfunction: State of the Art Stanley Rockson
July 21, 2007 Microbial Pathogenesis: Mechanisms of Infectious Disease Type I interferon signaling is required for activation of the inflammasome during Francisella infection Denise M Monack,
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.